Piero Montorsi

Showing 1-3 of 3 articles

Coronary interventions

Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Nuruddin A, Lee M

February 7, 2020 | 10.4244/EIJ-D-18-01058

Interventions for stroke

AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure

Trabattoni D, Gaspardone A, Sgueglia G, Fabbiocchi F, Gioffrè G, Montorsi P, Calligaris G, Iamele M, De Santis A, Bartorelli A

April 20, 2017 | 10.4244/EIJ-D-15-00499

Use of the Venture™ wire control catheter to access complex coronary lesions: how to turn procedural failure into success

Aranzulla T, Sangiorgi G, Bartorelli A, Cosgrave J, Corbett S, Fabbiocchi F, Montorsi P, Montorfano M, Trabattoni D, Colombo A

August 20, 2008

1

Latest news

Lipid-lowering therapy and PCI; thin vs thick stents; mini focus on STEMI; and more…

Outcomes of transcatheter tricuspid valve intervention by right ventricular function

Florian Schlotter et al.

How to eliminate mitral regurgitation definitively: the eternal dilemma?

Thomas Modine et al.

EBC 15th consensus document - Watch the Chat!

Relive the 2nd edition

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

To be better among the best: a difficult task

Antonio Colombo et al.

New JAA's: Calcification of PAD by OFDI and IVUS, Simultaneous PTVR reversing right-left shunts following PMVR?...

Valvular disease